In the context of receptor targeting, discovery of human epidermal growth factor receptor 2 (HER2) has revolutionized anti-cancer therapies, in particular for personalized medicine in HER2 receptor amplified breast cancer patients. The gene discussed is ERBB2; the disease is breast cancer.